161 related articles for article (PubMed ID: 11424405)
41. Standard chemotherapy for gastric carcinoma: is it a myth?
Ajani JA
J Clin Oncol; 2000 Dec; 18(23):4001-3. PubMed ID: 11099333
[No Abstract] [Full Text] [Related]
42. RCT makes standardization of chemotherapy possible for advanced gastric cancers including outpatient-based chemotherapy.
Munakata M; Sakata Y
Nihon Shokakibyo Gakkai Zasshi; 2008 Mar; 105(3):351-60. PubMed ID: 18332599
[No Abstract] [Full Text] [Related]
43. [Chemotherapy for human gastric cancer: a review].
Demolin G; Focan C; Plomteux O; Kreutz F; Moeneclaey N; Focan-Henrard D
Rev Med Liege; 2008 Sep; 63(9):532-41. PubMed ID: 19051508
[TBL] [Abstract][Full Text] [Related]
44. [New chemotherapeutic options in advanced gastric cancer].
Höhler T; Möhler M
Onkologie; 2003 Dec; 26 Suppl 7():54-9. PubMed ID: 14716144
[TBL] [Abstract][Full Text] [Related]
45. Patient heterogeneity and allocation bias: how should they be reported in clinical trials of chemotherapy for advanced gastric cancer?
Hyodo I
Gastric Cancer; 2012 Apr; 15(2):115-7. PubMed ID: 22252154
[No Abstract] [Full Text] [Related]
46. [Upper G.I. Cancer. IV. Is Conversion Therapy Possible for Stage IV Gastric Cancer?].
Okumura N; Yoshida K; Yamaguchi K; Tanahashi T; Tanaka Y
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1064-7. PubMed ID: 26529803
[No Abstract] [Full Text] [Related]
47. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Okines A; Verheij M; Allum W; Cunningham D; Cervantes A;
Ann Oncol; 2010 May; 21 Suppl 5():v50-4. PubMed ID: 20555102
[No Abstract] [Full Text] [Related]
48. [Chemotherapy of hematological malignancies based on EBM].
Ueda R
Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():147-53. PubMed ID: 11989255
[No Abstract] [Full Text] [Related]
49. Chemotherapy of advanced gastric carcinoma: to be completely rewritten?
Cocconi G
Ann Oncol; 1994 Jan; 5(1):8-11. PubMed ID: 8172797
[No Abstract] [Full Text] [Related]
50. [Decision making: how to choice anticancer chemotherapy].
Nishiyama M; Sekikawa T
Nihon Rinsho; 2001 Apr; 59 Suppl 4():344-9. PubMed ID: 11424404
[No Abstract] [Full Text] [Related]
51. International Phase III clinical trial demonstrates efficacy of a new second-line drug for gastric cancer.
Webb E
Immunotherapy; 2013 Dec; 5(12):1276. PubMed ID: 24283847
[No Abstract] [Full Text] [Related]
52. Adjuvant therapy in resectable gastric cancer.
Bleiberg H; Gerard B; Deguiral P
Br J Cancer; 1992 Dec; 66(6):987-91. PubMed ID: 1457367
[No Abstract] [Full Text] [Related]
53. 2016 ASCO Gastrointestinal Cancers Symposium.
Landman A
Lancet Oncol; 2016 Mar; 17(3):282. PubMed ID: 26831286
[No Abstract] [Full Text] [Related]
54. Chemotherapy in gastric cancer: a never ending saga.
Roth AD
Ann Oncol; 2003 Feb; 14(2):175-7. PubMed ID: 12562640
[No Abstract] [Full Text] [Related]
55. Searching for a standard.
Cohen EE; Vokes EE
J Clin Oncol; 2002 Jan; 20(2):359-61. PubMed ID: 11786560
[No Abstract] [Full Text] [Related]
56. Where there are no randomized, phase 3 trials: what is a doctor to do?
Gross TG
J Pediatr Hematol Oncol; 2008 Oct; 30(10):719-20. PubMed ID: 19011465
[No Abstract] [Full Text] [Related]
57. More randomization in phase II trials: necessary but not sufficient.
Rubinstein L; Leblanc M; Smith MA
J Natl Cancer Inst; 2011 Jul; 103(14):1075-7. PubMed ID: 21709273
[No Abstract] [Full Text] [Related]
58. A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer.
Zhang Y; Wang ZX; Shen L; Li J; Huang J; Su WG; Zhang DS; Xu RH
Cancer Commun (Lond); 2023 Jan; 43(1):150-153. PubMed ID: 36331272
[No Abstract] [Full Text] [Related]
59. The treatment of advanced gastric cancer: in search of the right combination.
Kulke MH
J Clin Oncol; 2000 Jul; 18(14):2645-7. PubMed ID: 10894862
[No Abstract] [Full Text] [Related]
60. Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer.
Shitara K; Ikeda J; Kondo C; Takahari D; Ura T; Muro K; Matsuo K
Gastric Cancer; 2012 Apr; 15(2):137-43. PubMed ID: 21842172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
